Skip to main content

Advertising Disclaimer »

Main menu

  • Journals
    • Pediatrics
    • Hospital Pediatrics
    • Pediatrics in Review
    • NeoReviews
    • AAP Grand Rounds
    • AAP News
  • Authors/Reviewers
    • Submit Manuscript
    • Author Guidelines
    • Reviewer Guidelines
    • Open Access
    • Editorial Policies
  • Content
    • Current Issue
    • Online First
    • Archive
    • Blogs
    • Topic/Program Collections
    • AAP Meeting Abstracts
  • Pediatric Collections
    • COVID-19
    • Racism and Its Effects on Pediatric Health
    • More Collections...
  • AAP Policy
  • Supplements
  • Multimedia
    • Video Abstracts
    • Pediatrics On Call Podcast
  • Subscribe
  • Alerts
  • Careers
  • Other Publications
    • American Academy of Pediatrics

User menu

  • Log in
  • My Cart

Search

  • Advanced search
American Academy of Pediatrics

AAP Gateway

Advanced Search

AAP Logo

  • Log in
  • My Cart
  • Journals
    • Pediatrics
    • Hospital Pediatrics
    • Pediatrics in Review
    • NeoReviews
    • AAP Grand Rounds
    • AAP News
  • Authors/Reviewers
    • Submit Manuscript
    • Author Guidelines
    • Reviewer Guidelines
    • Open Access
    • Editorial Policies
  • Content
    • Current Issue
    • Online First
    • Archive
    • Blogs
    • Topic/Program Collections
    • AAP Meeting Abstracts
  • Pediatric Collections
    • COVID-19
    • Racism and Its Effects on Pediatric Health
    • More Collections...
  • AAP Policy
  • Supplements
  • Multimedia
    • Video Abstracts
    • Pediatrics On Call Podcast
  • Subscribe
  • Alerts
  • Careers

Discover Pediatric Collections on COVID-19 and Racism and Its Effects on Pediatric Health

American Academy of Pediatrics
From the American Academy of PediatricsClinical Report

Counseling Parents and Teens About Marijuana Use in the Era of Legalization of Marijuana

Sheryl A. Ryan, Seth D. Ammerman and COMMITTEE ON SUBSTANCE USE AND PREVENTION
Pediatrics March 2017, 139 (3) e20164069; DOI: https://doi.org/10.1542/peds.2016-4069
Sheryl A. Ryan
aDepartment of Pediatrics/Adolescent Medicine, Yale University School of Medicine, New Haven, Connecticut; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Seth D. Ammerman
bDepartment of Pediatrics/Adolescent Medicine, Stanford University School of Medicine, Stanford, California
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • Comments
Loading
Download PDF

Abstract

Many states have recently made significant changes to their legislation making recreational and/or medical marijuana use by adults legal. Although these laws, for the most part, have not targeted the adolescent population, they have created an environment in which marijuana increasingly is seen as acceptable, safe, and therapeutic. This clinical report offers guidance to the practicing pediatrician based on existing evidence and expert opinion/consensus of the American Academy of Pediatrics regarding anticipatory guidance and counseling to teenagers and their parents about marijuana and its use. The recently published technical report provides the detailed evidence and references regarding the research on which the information in this clinical report is based.

  • Abbreviations:
    AAP —
    American Academy of Pediatrics
    SBIRT —
    Screening, Brief Intervention, and Referral for Treatment
  • Background

    The legalization of medical marijuana in many states and the District of Columbia and the outright legalization of recreational marijuana for adults aged 21 years and older in a few states and the District of Columbia have resulted in changes in the access to and availability of this drug. Most of these states now allow the use of marijuana for a variety of medical conditions in adults as well as in children (with parental permission). In addition, many states have reduced penalties for the recreational use of marijuana; criminal penalties have been reduced from felonies in some cases to misdemeanors or infractions.1 For up-to-date information on the numbers of states allowing these laws related to marijuana use, the reader is referred to www.aap.org/marijuana.

    Although there are currently no initiatives to legalize the recreational use of marijuana for minors and marijuana is still a federally controlled substance, changes in the legal status of marijuana, even if limited to adults, may affect use among adolescents by decreasing the perceived risk of harm or through the marketing of legal marijuana, despite restrictions that prohibit marketing and advertising to this age group. The National Survey on Drug Use and Health recently documented a decline in the percentage of 12- to 17-year-olds who perceived that there is “great risk” in smoking marijuana once a month or 1 to 2 times per week, which is concerning, because the same survey has documented that decreases in perceived risk typically precede or occur at the same time as increases in use.2 The concentration of tetrahydrocannabinol, or THC, the psychoactive substance in the marijuana plant, has increased considerably, from approximately 4% in the early 1980s to upward of 12% in 2012,3 increasing the risk of adverse effects and the potential for addiction.

    Studies have been conducted in adults to research the potential therapeutic effects of the class of chemicals known as cannabinoids (the active compounds in marijuana) administered either as a pharmaceutical preparation or as marijuana leaves, distilled oils, or edibles and drinkables. Cannabinoids have been shown to be helpful for adults in addressing some symptoms, such as increasing appetite and decreasing nausea and vomiting in patients receiving chemotherapy and reducing pain in chronic neuropathic pain syndromes. Cannabinoids may have adverse effects, however, such as dizziness, dysphoria, and clouded sensorium.4,5 The only studies that have been published on the use or efficacy of medicinal marijuana in children and adolescents have been limited to its use in the treatment of refractory seizures.6,7

    The adverse effects of marijuana have been well documented. Numerous published studies have shown the potential negative consequences of short- and long-term use of recreational marijuana in adolescents.8 These consequences include impaired short-term memory and decreased concentration, attention span, and problem-solving skills, all of which interfere with learning. Alterations in motor control, coordination, judgment, reaction time, and tracking ability have also been documented. These effects may contribute to unintentional deaths and injuries among adolescents, especially those who drive after using marijuana. Negative health effects on lung function associated with smoking marijuana also have been documented9; in addition, longitudinal studies linking marijuana use with higher rates of mental health disorders, such as depression and psychosis, recently have been published, raising concerns about longer-term psychiatric effects.8,10 Secondhand marijuana smoke can also be detected in adults who are passively exposed, and new data also suggest that secondhand marijuana smoke may be harmful to children.11 A recent study found that in an inpatient sample of infants admitted for respiratory compromise, 1 in 6 had detectable traces of marijuana in their systems.12

    The adolescent brain, particularly the prefrontal cortex areas that control judgment and decision-making, is not fully developed until the early 20s, raising questions about how any substance use may affect the developing brain.8,13–15 Studies examining brain functioning in youth who use cannabis regularly or heavily (defined as using 10–19 times/month or 20 or more times/month, respectively) show potential abnormalities that occur across a number of brain regions including those affecting memory (hippocampus) and executive functioning and planning (prefrontal cortex).13–15 Studies assessing the role of marijuana on brain morphology are inconsistent, with 1 study citing increased and decreased volumes of subcortical structures16 and another citing no effect on structures such as the amygdala and hippocampus.17 A major study also has shown that long-term marijuana use initiated in adolescence has negative effects on intellectual function and that the deficits in cognitive areas, such as executive function and processing speed, did not recover by adulthood, even when cannabis use was discontinued.18

    As with other psychoactive substances, the younger an adolescent begins using drugs, including marijuana, the more likely it is that drug dependence or addiction will develop in adulthood.15,19 Evidence clearly shows that marijuana is an addictive substance; overall, 9% of those experimenting with marijuana will become addicted; this percentage increases to 17% among those who initiate marijuana use in adolescence and to a range of between 25% and 50% among teenagers who smoke marijuana daily.20 It should be noted that most teenage patients addicted to marijuana do not have lifelong addiction; however, significant effects on cognitive and psychosocial function may occur during the addiction period.21

    Marijuana use during pregnancy has adverse effects on the fetus, including growth retardation. Longer-term consequences of prenatal marijuana use that have been reported in infants and children include subtle deficits in learning and memory as well as deficits in executive functions, such as problem-solving skills that require sustained attention, analysis, and integration.22

    Role of the Pediatrician

    Pediatricians are in an influential position to counteract the perception of teenage marijuana use as benign. Research findings regarding the health effects of marijuana on children and adolescents provide guidance for parents and their children. The office setting provides an excellent opportunity for education and counseling to prevent marijuana use as well as to implement brief interventions and referrals if needed. Parents who use marijuana may not fully realize the problems that their own use may present for their children’s health; the effect that their modeling of recreational use may have on their child, adolescent, or young adult23,24; or the risks of ingestion25,26 and/or secondhand smoke.9

    The American Academy of Pediatrics (AAP) recognizes that parents may choose to administer marijuana to children with severely debilitating or severe chronic conditions when other standard therapies have proven inadequate or in compassionate care/end-of-life care situations and that they may seek support for this practice from their child’s pediatrician. However, because marijuana use is still considered a federal offense, there may be legal ramifications for a pediatrician formally recommending the use of medical marijuana in these extenuating circumstances. Awareness of one’s state laws and protections for medical providers is essential, and direct discussion of this issue with one’s state medical board may be appropriate.

    The following sections include key facts and suggested talking points for the pediatrician to use in speaking with youth and their parents about marijuana and the effects of its use. For detailed references to the data listed in this statement, the reader is referred to the full technical report published by the AAP.1

    Office Approach to the Adolescent Patient

    1. Adolescents and preteens may be screened for substance use and brief intervention, as recommended in the Screening, Brief Intervention, and Referral for Treatment (SBIRT) policy statement.27 The effectiveness of the SBIRT technique has been documented in adults with alcohol use problems; because of the lack of information in the adolescent population, the US Preventive Services Task Force recently gave SBIRT an “I” rating, stating that there was insufficient evidence to recommend either for or against this technique. However, on the basis of the limited evidence available and the low cost of this brief intervention, the AAP and the National Institute on Alcohol Abuse and Alcoholism both recommend that this technique be used in pediatric practices as part of routine care.

    2. For adolescents who do not use marijuana, motivational techniques may be helpful in eliciting reasons for abstaining from use and resisting peer pressure in a manner that supports their decision to abstain.

    3. Adolescents who use marijuana regularly or heavily are more likely to meet criteria for a substance use disorder. For these teenagers, a brief motivational intervention may be used to target: (1) reducing use and (2) continuing the conversation either with the pediatrician or a mental health or behavioral counselor. Additional advice for gathering information that is helpful to determine the extent and severity of use follows:

      • Ask the adolescent how much and how often he or she uses marijuana. Also ask about the circumstances (ie, where the marijuana is obtained, if use is with others versus alone, if use is before or during school versus on the weekends) and motivations (when stressed, bored, alone, angry, etc) associated with the decision to use the substance. Although teenagers may use marijuana for the positive euphoric effects or for social acceptance, they also may use marijuana for self-medication, such as to relieve negative moods (ie, stress, anxiety, or depression)28 or for sleep problems. Teenagers who use marijuana for these purposes who meet criteria for a co-occurring mental health disorder may benefit from treatment, including counseling and/or a psychiatric evaluation.

      • Take a detailed history that includes identifying concerns associated with marijuana use. Criteria in the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (see Table 1), can be useful as a guideline in ruling out problematic marijuana use.29

      • If the adolescent does not report regular use of marijuana and denies any associated problems, offer a “challenge.” Ask the adolescent to quit using the drug for a brief period of time, and see what happens. If the adolescent is able to stop completely, ask whether life was “better, worse, or the same” during the quit period to prompt a discussion of pros and cons of use. If the adolescent was unable to stop completely, explore possible triggers and high-risk situations that were barriers to success. Work with the adolescent to problem-solve and try again. If the adolescent was unwilling to quit, even for a limited period of time, explore the motivations for drug use (see talking point 1) and consider whether any additional interventions or supports may be helpful. Talking points can be introduced as areas of concern but also can be used to trigger engagement and discussion during brief interventions (eg, information about the modeling effect of parental smoking and the current understanding of marijuana effects in teenagers). If there are major concerns for the teenager’s safety or the teenager is considered at high risk of adverse consequences, breaking confidentiality and notifying the parents may be advisable to ensure the patient’s safety.

    View this table:
    • View inline
    • View popup
    TABLE 1

    DSM-5 Criteria for Marijuana Use Disorder29

    Talking Points for Parents and Teens: Handout

    1. Marijuana is not a benign drug for teens. The teen brain is still developing, and marijuana may cause abnormal brain development.

    2. Teens who use marijuana regularly may develop serious mental health disorders, including addiction, depression, and psychosis.

    3. There are no research studies on the use of medical marijuana in teens, so actual indications, appropriate dosing, effects, and side effects are unknown. The only data available on medical marijuana in the pediatric population are limited to its use in children with severe refractory seizures.

    4. Recreational use of marijuana by minors and young adults under the age of 21 years is illegal and, if prosecuted, may result in a permanent criminal record, affecting schooling, jobs, etc.

    5. Never drive under the influence of marijuana or ride in a car with a driver who is under the influence of marijuana. Adults and teens regularly get into serious and even fatal car accidents while under the influence of marijuana.

    6. Marijuana smoke is toxic, similar to secondhand tobacco smoke. The use of vaporizers or hookahs does not eliminate the toxic chemicals in marijuana smoke.

    7. For parents: You are role models for your children, and actions speak louder than words. So if you use marijuana in front of your teens, they are more likely to use it themselves, regardless of whether you tell them not to. (See the AAP Healthy Children Web site: www.healthychildren.org/English/ages-stages/teen/substance-abuse/Pages/Drug-Abuse-Prevention-Starts-with-Parents.aspx.)

    8. For parents: It is important to keep all marijuana products away from children. As with other medications and toxic products, containers that are child-proof and kept out of reach should be used. For small children, marijuana edibles and drinks can be particularly dangerous.

    9. For parents: Remember that intoxication and euphoria are predictable effects of using marijuana products. Being “high” from your own recreational or medical marijuana use may alter your capacity to function safely as a parent or to provide a safe environment for infants and children.30

    10. For parents: If your child asks you directly whether you have used marijuana, a brief, honest answer may help the child feel comfortable talking with you about drug use issues. However, it is best to not share your own histories of drug use with your children. Rather, discussion of drug use scenarios, in general, may be a more helpful approach.

    Summary and Conclusions

    Pediatricians are in a unique position to provide parents and teenagers with accurate information and counseling regarding the consequences of marijuana or cannabis use by children, teenagers, and adults. A number of strategies can be used to counsel families about preventing use and to intervene if marijuana is being used either recreationally or medically by the families for whom they provide medical care.

    Authors

    Sheryl A. Ryan, MD, FAAP

    Seth D. Ammerman, MD, FAAP

    Committee on Substance Use and Prevention, 2016–2017

    Sheryl A. Ryan, MD, FAAP, Chairperson

    Pamela K. Gonzalez, MD, MS, FAAP

    Stephen W. Patrick, MD, MPH, MS, FAAP

    Joanna Quigley, MD, FAAP

    Leslie R. Walker, MD, FAAP

    Former Committee Members

    Seth D. Ammerman, MD, FAAP

    Sharon Levy, MD, MPH, FAAP

    Lorena Siqueira, MD, MSPH, FAAP

    Vincent C. Smith, MD, MPH, FAAP

    Liaisons

    Vivian B. Faden, PhD – National Institute of Alcohol Abuse and Alcoholism

    Gregory Tau, MD, PhD – American Academy of Child and Adolescent Psychiatry

    Staff

    Renee Jarrett, MPH

    Footnotes

    • Address correspondence to Sheryl Ryan, MD, FAAP. E-mail: sheryl.ryan{at}yale.edu
    • This document is copyrighted and is property of the American Academy of Pediatrics and its Board of Directors. All authors have filed conflict of interest statements with the American Academy of Pediatrics. Any conflicts have been resolved through a process approved by the Board of Directors. The American Academy of Pediatrics has neither solicited nor accepted any commercial involvement in the development of the content of this publication.

    • Clinical reports from the American Academy of Pediatrics benefit from expertise and resources of liaisons and internal (AAP) and external reviewers. However, clinical reports from the American Academy of Pediatrics may not reflect the views of the liaisons or the organizations or government agencies that they represent.

    • The guidance in this report does not indicate an exclusive course of treatment or serve as a standard of medical care. Variations, taking into account individual circumstances, may be appropriate.

    • All clinical reports from the American Academy of Pediatrics automatically expire 5 years after publication unless reaffirmed, revised, or retired at or before that time.

    • FINANCIAL DISCLOSURE: The authors have indicated they do not have a financial relationship relevant to this article to disclose.

    • FUNDING: No external funding.

    • POTENTIAL CONFLICT OF INTEREST: The authors have indicated they have no potential conflicts of interest to disclose.

    References

    1. ↵
      1. Ammerman S,
      2. Ryan S,
      3. Adelman WP; Committee on Substance Abuse; Committee on Adolescence
      . The impact of marijuana policies on youth: clinical, research, and legal update. Pediatrics. 2015;135(3). Available at: www.pediatrics.org/cgi/content/full/135/3/e769pmid:25624385
      OpenUrlAbstract/FREE Full Text
    2. ↵
      Results from the 2013 National Survey on Drug Use and Health: summary of national findings. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2014. Available at: www.samhsa.gov/data/sites/default/files/NSDUHresultsPDFWHTML2013/Web/NSDUHresults2013.pdf. Accessed October 6, 2016
    3. ↵
      1. El Sohly MA
      . Potency Monitoring Project. Quarterly report 123—reporting period: 09/16/2013–12/15/2013. Oxford, MS: University of Mississippi, National Center for Natural Products Research; 2014
    4. ↵
      1. Aggarwal SK,
      2. Carter GT,
      3. Sullivan MD,
      4. ZumBrunnen C,
      5. Morrill R,
      6. Mayer JD
      . Medicinal use of cannabis in the United States: historical perspectives, current trends, and future directions. J Opioid Manag. 2009;5(3):153–168pmid:19662925
      OpenUrlPubMed
    5. ↵
      1. Cotter J
      . Efficacy of crude marijuana and synthetic delta-9-tetrahydrocannabinol as treatment for chemotherapy-induced nausea and vomiting: a systematic literature review. Oncol Nurs Forum. 2009;36(3):345–352pmid:19596652
      OpenUrlCrossRefPubMed
    6. ↵
      1. Press CA,
      2. Knupp KG,
      3. Chapman KE
      . Parental reporting of response to oral cannabis extracts for treatment of refractory epilepsy. Epilepsy Behav. 2015;45:49–52pmid:25845492
      OpenUrlCrossRefPubMed
    7. ↵
      1. Devinsky O,
      2. Marsh E,
      3. Friedman D, et al
      . Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial. Lancet Neurol. 2016;15(3):270–278pmid:26724101
      OpenUrlCrossRefPubMed
    8. ↵
      1. Volkow ND,
      2. Baler RD,
      3. Compton WM,
      4. Weiss SR
      . Adverse health effects of marijuana use. N Engl J Med. 2014;370(23):2219–2227pmid:24897085
      OpenUrlCrossRefPubMed
    9. ↵
      1. Joshi M,
      2. Joshi A,
      3. Bartter T
      . Marijuana and lung diseases. Curr Opin Pulm Med. 2014;20(2):173–179pmid:24384575
      OpenUrlCrossRefPubMed
    10. ↵
      1. Evins AE,
      2. Green AI,
      3. Kane JM,
      4. Murray RM
      . The effect of marijuana use on the risk for schizophrenia. J Clin Psychiatry. 2012;73(11):1463–1468pmid:23218162
      OpenUrlPubMed
    11. ↵
      1. Cone EJ,
      2. Roache JD,
      3. Johnson RE
      . Effects of passive exposure to marijuana smoke. NIDA Res Monogr. 1987;76:150–156pmid:2830518
      OpenUrlPubMed
    12. ↵
      1. Wilson K,
      2. Torok M,
      3. Wei B, et al
      . Marijuana smoke exposure in children hospitalized for bronchiolitis. Presented at: Pediatric Academic Societies Annual Meeting; April 30–May 3, 2016; Baltimore, MD
    13. ↵
      1. Schepis TS,
      2. Adinoff B,
      3. Rao U
      . Neurobiological processes in adolescent addictive disorders. Am J Addict. 2008;17(1):6–23pmid:18214718
      OpenUrlCrossRefPubMed
      1. Schweinsburg AD,
      2. Brown SA,
      3. Tapert SF
      . The influence of marijuana use on neurocognitive functioning in adolescents. Curr Drug Abuse Rev. 2008;1(1):99–111pmid:19630709
      OpenUrlCrossRefPubMed
    14. ↵
      1. Hammond CJ,
      2. Mayes LC,
      3. Potenza MN
      . Neurobiology of adolescent substance use and addictive behaviors: treatment implications. Adolesc Med State Art Rev. 2014;25(1):15–32pmid:25022184
      OpenUrlPubMed
    15. ↵
      1. Battistella G,
      2. Fornari E,
      3. Annoni JM, et al
      . Long-term effects of cannabis on brain structure. Neuropsychopharmacology. 2014;39(9):2041–2048pmid:24633558
      OpenUrlCrossRefPubMed
    16. ↵
      1. Weiland BJ,
      2. Thayer RE,
      3. Depue BE,
      4. Sabbineni A,
      5. Bryan AD,
      6. Hutchison KE
      . Daily marijuana use is not associated with brain morphometric measures in adolescents or adults. J Neurosci. 2015;35(4):1505–1512pmid:25632127
      OpenUrlAbstract/FREE Full Text
    17. ↵
      1. Meier MH,
      2. Caspi A,
      3. Ambler A, et al
      . Persistent cannabis users show neuropsychological decline from childhood to midlife. Proc Natl Acad Sci USA. 2012;109(40):E2657–E2664pmid:22927402
      OpenUrlAbstract/FREE Full Text
    18. ↵
      1. Winters KC,
      2. Lee CY
      . Likelihood of developing an alcohol and cannabis use disorder during youth: association with recent use and age. Drug Alcohol Depend. 2008;92(1–3):239–247pmid:17888588
      OpenUrlCrossRefPubMed
    19. ↵
      1. Hall W,
      2. Degenhardt L
      . Adverse health effects of non-medical cannabis use. Lancet. 2009;374(9698):1383–1391pmid:19837255
      OpenUrlCrossRefPubMed
    20. ↵
      1. Farmer RF,
      2. Kosty DB,
      3. Seeley JR, et al
      . Natural course of cannabis use disorders. Psychol Med. 2015;45(1):63–72pmid:25066537
      OpenUrlPubMed
    21. ↵
      1. Behnke M,
      2. Smith VC; Committee on Substance Abuse; Committee on Fetus and Newborn
      . Prenatal substance abuse: short- and long-term effects on the exposed fetus. Pediatrics. 2013;131(3). Available at: www.pediatrics.org/cgi/content/full/131/3/e1009pmid:23439891
      OpenUrlAbstract/FREE Full Text
    22. ↵
      National Center on Addiction and Substance Abuse. Adolescent substance use: America’s #1 public health problem. New York, NY: National Center on Addiction and Substance Abuse (CASA); June 2011:64, 264. Available at: www.casacolumbia.org/addiction-research/reports/adolescent-substance-use. Accessed October 6, 2016
    23. ↵
      1. Napper LE,
      2. Hummer JF,
      3. Chithambo TP,
      4. LaBrie JW
      . Perceived parent and peer marijuana norms: the moderating effect of parental monitoring during college. Prev Sci. 2015;16(3):364–373pmid:24838776
      OpenUrlPubMed
    24. ↵
      1. Moon MA
      . Striking rise in accidental marijuana poisonings. Pediatric News Digital Network. May 28, 2013. Available at: www.pediatricnews.com/?id=7791&tx_ttnews[tt_news]=143729&cHash=5453c65f0404a55f3451852940acace6. Accessed October 6, 2016
    25. ↵
      1. Wang GS,
      2. Roosevelt G,
      3. Heard K
      . Pediatric marijuana exposures in a medical marijuana state. JAMA Pediatr. 2013;167(7):630–633pmid:23712626
      OpenUrlCrossRefPubMed
    26. ↵
      1. Committee on Substance Use and Prevention
      . Substance use screening, brief intervention, and referral to treatment. Pediatrics. 2016;138(1):e20161210pmid:27325638
      OpenUrlAbstract/FREE Full Text
    27. ↵
      1. Shrier LA,
      2. Ross CS,
      3. Blood EA
      . Momentary positive and negative affect preceding marijuana use events in youth. J Stud Alcohol Drugs. 2014;75(5):781–789pmid:25208196
      OpenUrlPubMed
    28. ↵
      1. American Psychiatric Association
      . Diagnostic and Statistical Manual of Mental Disorders. 5th ed. Arlington, VA: American Psychiatric Association; 2013
    29. ↵
      1. Substance Abuse and Mental Health Services Administration
      . Handout: the effects of substance abuse on behavior and parenting. Available at: https://www.ncsacw.samhsa.gov/files/TrainingPackage/MOD2/EffectsofSubstanceAbuse.pdf. Accessed October 6, 2016
    • Copyright © 2017 by the American Academy of Pediatrics
    PreviousNext
    Back to top

    Advertising Disclaimer »

    In this issue

    Pediatrics
    Vol. 139, Issue 3
    1 Mar 2017
    • Table of Contents
    • Index by author
    View this article with LENS
    PreviousNext
    Email Article

    Thank you for your interest in spreading the word on American Academy of Pediatrics.

    NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

    Enter multiple addresses on separate lines or separate them with commas.
    Counseling Parents and Teens About Marijuana Use in the Era of Legalization of Marijuana
    (Your Name) has sent you a message from American Academy of Pediatrics
    (Your Name) thought you would like to see the American Academy of Pediatrics web site.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Request Permissions
    Article Alerts
    Log in
    You will be redirected to aap.org to login or to create your account.
    Or Sign In to Email Alerts with your Email Address
    Citation Tools
    Counseling Parents and Teens About Marijuana Use in the Era of Legalization of Marijuana
    Sheryl A. Ryan, Seth D. Ammerman, COMMITTEE ON SUBSTANCE USE AND PREVENTION
    Pediatrics Mar 2017, 139 (3) e20164069; DOI: 10.1542/peds.2016-4069

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
    Share
    Counseling Parents and Teens About Marijuana Use in the Era of Legalization of Marijuana
    Sheryl A. Ryan, Seth D. Ammerman, COMMITTEE ON SUBSTANCE USE AND PREVENTION
    Pediatrics Mar 2017, 139 (3) e20164069; DOI: 10.1542/peds.2016-4069
    del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
    Print
    Download PDF
    Insight Alerts
    • Table of Contents

    Jump to section

    • Article
      • Abstract
      • Background
      • Role of the Pediatrician
      • Talking Points for Parents and Teens: Handout
      • Summary and Conclusions
      • Authors
      • Committee on Substance Use and Prevention, 2016–2017
      • Former Committee Members
      • Liaisons
      • Staff
      • Footnotes
      • References
    • Figures & Data
    • Info & Metrics
    • Comments

    Related Articles

    • No related articles found.
    • PubMed
    • Google Scholar

    Cited By...

    • Public Appeals Challenging Criteria for Pediatric Organ Transplantation
    • Cannabis in homes with children: use and storage practices in a legalised state
    • Google Scholar

    More in this TOC Section

    • Ethical Considerations in Pediatricians’ Use of Social Media
    • 2021 Recommendations for Preventive Pediatric Health Care
    • Recommended Childhood and Adolescent Immunization Schedule: United States, 2021
    Show more From the American Academy of Pediatrics

    Similar Articles

    Subjects

    • Current Policy
    • Substance Use
      • Substance Use
    • AAP Policy Collections by Authoring Entities
      • Committee on Substance Use and Prevention
    • Journal Info
    • Editorial Board
    • Editorial Policies
    • Overview
    • Licensing Information
    • Authors/Reviewers
    • Author Guidelines
    • Submit My Manuscript
    • Open Access
    • Reviewer Guidelines
    • Librarians
    • Institutional Subscriptions
    • Usage Stats
    • Support
    • Contact Us
    • Subscribe
    • Resources
    • Media Kit
    • About
    • International Access
    • Terms of Use
    • Privacy Statement
    • FAQ
    • AAP.org
    • shopAAP
    • Follow American Academy of Pediatrics on Instagram
    • Visit American Academy of Pediatrics on Facebook
    • Follow American Academy of Pediatrics on Twitter
    • Follow American Academy of Pediatrics on Youtube
    • RSS
    American Academy of Pediatrics

    © 2021 American Academy of Pediatrics